Concepedia

Phase I study of the investigational, oral pan-RAF kinase inhibitor TAK-580 (MLN2480) in patients with advanced solid tumors (ST) or melanoma (MEL): Final analysis

Anthony J. Olszanski, René González, Pippa Corrie, Anne C. Pavlick, Mark R. Middleton, Paul Lorigan, Ruth Plummer, S. Skaria, C Herbert, Martin Gore,

Annals of Oncology · 2017 · 12 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyOncology PharmacotherapyMalignant NeoplasmsMelanoma PharmacotherapySolid Tumor OncologyTyrosine Kinase InhibitorsMek InhibitionMek InhibitorsRaf SignalingRaf-mek-erk SignalingTyrosine Kinase Inhibitor Therapy